"We Inspire hope. We Inspire you."
US-based digital rehabilitation company offering FDA-cleared robotic gloves and gamified therapy devices for stroke and neurological recovery.
Neofect is a South Korean-founded, US-headquartered digital rehabilitation company established in June 2010 by Hoyoung Ban and Scott Kim, graduates of the University of Virginia's Darden School of Business, along with Young Choi, PhD, of the University of Southern California specializing in stroke rehabilitation algorithms and robotics. The company's mission is to make high-quality rehabilitation accessible to patients recovering from stroke, spinal cord injury, and other neurological conditions through clinically validated, technology-driven exercise devices.
Neofect's flagship product line is the RAPAEL (Robotic rehabilitation system using Artificial intelligence for neuromuscular feedback and motivation via Adaptive exercising with gamesifiEd Linking) Smart Glove, which received FDA clearance in 2014. The RAPAEL Smart Glove measures forearm, wrist, and individual finger movements using a 9-axis motion sensor (3-axis accelerometer, 3-axis gyroscope, 3-axis magnetometer) and bending sensors, enabling real-time biomechanical evaluation. Patients perform gamified, occupation-based exercises in a virtual environment that tracks range of motion and generates clinical outcome reports. Clinical trials demonstrated statistically significant improvements on the Fugl-Meyer Assessment of Motor Recovery After Stroke and the Jebsen-Taylor Hand Function Test versus dose-matched conventional occupational therapy controls.
The NeoMano, launched in 2018, is Neofect's wearable robotic glove for patients with hand paralysis due to spinal cord injury or stroke. It wraps around the palm and index and middle fingers, controlled by a body-movement sensor on the elbow or arm to activate grip and release. The device offers up to eight hours of battery life and is designed for everyday functional use, not just clinic-based rehabilitation.
Neofect also produces the RAPAEL Smart Pegboard and RAPAEL Smart Board for a broader range of upper extremity rehabilitation tasks, and RAPAEL Smart Kids for pediatric rehabilitation. The company has raised funding across seven rounds totaling over $12 million, with the latest Post-IPO equity round in July 2019. Operations span South Korea (Seongnam headquarters), San Francisco, California (US office at 530 Howard St, Suite 100), and Germany. Neofect's devices target occupational therapists, hospitals, rehabilitation centers, and home users, positioning the company at the intersection of medical devices and interactive rehabilitation technology.
Primary type & automation activities this supplier delivers:
FDA-cleared gamified rehabilitation glove for stroke patients measuring wrist and finger motion with 9-axis sensors.
Wearable robotic glove for daily use by patients with hand paralysis, actuating grip and release via body-movement sensor.
Contact Neofect US
WEBSITE
https://www.neofect.com/usPHONE
-10494HEADQUARTERS
United States
Company Facts
Founded
2010
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
Certifications & Memberships